Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Mar 18 12:27PM ET
21.02
Dollar change
-0.95
Percentage change
-4.32
%
IndexRUT P/E- EPS (ttm)-2.60 Insider Own33.35% Shs Outstand31.12M Perf Week-10.09%
Market Cap675.30M Forward P/E- EPS next Y-3.66 Insider Trans0.00% Shs Float21.41M Perf Month-14.16%
Income-84.97M PEG- EPS next Q-0.85 Inst Own87.01% Short Float25.33% Perf Quarter-10.55%
Sales6.24M P/S108.22 EPS this Y-33.43% Inst Trans24.34% Short Ratio18.93 Perf Half Y-27.41%
Book/sh11.33 P/B1.86 EPS next Y-7.43% ROA-30.69% Short Interest5.42M Perf Year-21.77%
Cash/sh8.57 P/C2.45 EPS next 5Y-16.78% ROE-32.60% 52W Range18.13 - 33.77 Perf YTD-3.57%
Dividend Est.- P/FCF- EPS past 5Y40.14% ROI-24.03% 52W High-37.75% Beta1.55
Dividend TTM- Quick Ratio15.22 Sales past 5Y12.93% Gross Margin93.39% 52W Low15.95% ATR (14)1.86
Dividend Ex-Date- Current Ratio15.22 EPS Y/Y TTM80.10% Oper. Margin-1633.74% RSI (14)44.05 Volatility8.29% 8.88%
Employees78 Debt/Eq0.00 Sales Y/Y TTM351.48% Profit Margin-1362.77% Recom1.17 Target Price52.60
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-13.87% Payout- Rel Volume0.64 Prev Close21.97
Sales Surprise38.71% EPS Surprise4.76% Sales Q/Q190.15% EarningsMar 11 AMC Avg Volume286.45K Price21.02
SMA20-5.01% SMA50-6.57% SMA200-17.16% Trades Volume88,011 Change-4.32%
Date Action Analyst Rating Change Price Target Change
Dec-20-24Initiated TD Cowen Buy
Oct-03-24Initiated Oppenheimer Outperform $48
Jul-26-24Initiated Robert W. Baird Outperform $58
Jun-27-24Initiated Cantor Fitzgerald Overweight
May-16-24Initiated H.C. Wainwright Buy $40
Feb-15-24Initiated Stifel Buy $44
Dec-26-23Initiated Jefferies Buy $22
Nov-22-23Initiated Wedbush Outperform $23
Oct-30-23Initiated Guggenheim Buy $45
Sep-28-23Initiated Raymond James Outperform $24
Mar-11-25 04:01PM
Mar-05-25 07:00AM
Feb-26-25 07:00AM
Jan-30-25 07:00AM
Jan-08-25 07:00AM
04:01PM Loading…
Nov-07-24 04:01PM
Nov-04-24 07:00AM
Oct-15-24 07:00AM
Sep-04-24 07:00AM
Aug-08-24 04:01PM
Jul-08-24 11:06AM
Jun-28-24 11:30AM
Jun-12-24 07:00AM
May-30-24 04:30PM
May-09-24 10:56PM
04:01PM Loading…
04:01PM
May-08-24 04:30PM
May-03-24 04:30PM
Apr-11-24 07:30AM
Apr-05-24 04:30PM
Mar-21-24 10:54PM
04:01PM
Mar-07-24 04:30PM
Feb-26-24 07:00AM
Feb-23-24 08:00AM
Jan-31-24 04:05PM
Jan-22-24 07:30AM
Jan-02-24 08:30AM
Dec-14-23 07:04AM
Nov-29-23 04:05PM
04:05PM Loading…
Nov-09-23 04:05PM
Sep-14-23 05:04PM
Aug-14-23 01:35PM
May-03-23 04:19PM
07:00AM
Mar-31-23 04:10PM
06:09AM
Mar-27-23 10:20AM
Feb-09-23 01:24PM
10:13AM
Feb-03-23 01:35PM
Feb-02-23 04:05PM
05:58AM
Jan-25-23 04:05PM
Dec-21-22 07:39AM
Dec-20-22 11:20AM
09:00AM
Dec-13-22 05:56AM
Dec-12-22 04:30PM
08:00AM
Nov-03-22 09:01AM
09:01AM
Nov-01-22 08:00AM
Oct-17-22 12:16PM
Sep-23-22 09:15AM
Aug-17-22 08:00AM
Aug-04-22 08:00AM
Aug-02-22 08:00AM
Jul-17-22 09:04AM
May-16-22 12:29PM
09:35AM
08:00AM
May-10-22 11:54AM
Apr-14-22 04:41PM
12:15PM
08:00AM
Mar-08-22 08:00AM
Mar-03-22 08:00AM
Feb-07-22 09:35AM
Jan-18-22 07:00AM
Jan-10-22 08:00AM
Jan-05-22 08:00AM
Dec-14-21 09:00AM
Nov-10-21 06:20AM
Nov-08-21 09:24AM
Nov-04-21 09:10AM
09:09AM
Oct-04-21 08:00AM
Sep-21-21 08:00AM
Sep-15-21 08:00AM
Aug-09-21 06:20AM
Aug-05-21 08:00AM
Aug-03-21 05:30PM
08:00AM
Aug-01-21 11:50AM
Jul-30-21 09:20PM
11:14AM
Jul-28-21 07:39PM
Jul-26-21 08:16PM
Jul-23-21 11:00AM
10:14AM
Jul-21-21 10:30PM
03:46PM
08:47AM
08:00AM
Jul-14-21 10:00AM
Jul-06-21 08:00AM
Jun-17-21 09:43AM
Jun-14-21 08:00AM
Jun-04-21 09:00AM
Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company. It designs and delivers novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company was founded on June 17, 2015 and is headquartered in New York, NY.